Intense migraines secondary to percutaneous closure of atrial septal defects.
In this study we evaluated the development of migraine after percutaneous closure of atrial septal defect. An abrupt and excruciating form of migraine developed shortly after shunt closure in 5 of 13 consecutive patients undergoing this procedure. A dramatic relief of pain was achieved almost instantaneously after administration of 300 mg of clopidogrel.
Sharifi
Mohsen
M
Section of Cardiology, Department of Medicine, Texas Tech University Health Sciences, Center, Odessa, Texas, USA. seyedmohsensharifi@yahoo.com
Dehghani
Majid
M
Mehdipour
Mahshid
M
Al-Bustami
Omar
O
Emrani
Farnaz
F
Burks
James
J
D000328:Adult; D006328:Cardiac Catheterization; D000077144:Clopidogrel; D017548:Echocardiography, Transesophageal; D005260:Female; D005500:Follow-Up Studies; D006344:Heart Septal Defects, Atrial / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D008297:Male; D020326:Migraine without Aura / Q000188:drug therapy / Q000209:etiology*; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications; D012720:Severity of Illness Index; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine